Cinqair IV Infusion Therapy

What is Cinqair?

Cinqair (reslizumab) is a biologic drug that is an add-on maintenance treatment for adults 18 years and older with ​severe eosinophilic asthma (EA). 

How does Cinqair work?

Eosinophils are normal white blood cells. People with eosinophilic asthma have increased levels of eosinophils, which worsens inflammation in their lungs and can cause severe asthma attacks. Cinqair has been proven to reduce eosinophil levels in the blood, which helps prevent asthma attacks, improve breathing and lung function, and better control asthma symptoms. 

How is Cinqair administered?

Cinqair is administered intravenously once every 4 weeks. The dose depends on body weight. Each infusion takes about 20-50 minutes. 

Click here to visit the pharmaceutical website for Cinqair. 

CINQAIR patient Assistance program

• Cost Support for CINQAIR Patients

This product may be used to treat other conditions not listed. If you are currently using or have a physician’s order to begin using this product for an unlisted condition and you have questions about whether or not we can offer you infusion services, please call our office or fill out a form and a member of our team will reach out to you as soon as possible.

If you’d like more information about the other treatment options we offer, please visit the IVIg infusions or biologic injections pages to learn more.